Skyhawk Therapeutics is based in Waltham, Massachusetts. It has raised $625M in total funding. Backed by Fidelity.
Skyhawk Therapeutics funding overview
Skyhawk Therapeutics is based in Waltham, Massachusetts. Skyhawk Therapeutics has raised $625M in total disclosed funding. That places its disclosed total in the $250M–$1B range. The round record for Skyhawk Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Fidelity.
Skyhawk Therapeutics at a glance
Total raised
$625M
Latest round date
January 2021
Headquarters
Waltham, Massachusetts
Notable investors
Fidelity
Frequently asked about Skyhawk Therapeutics funding
How much has Skyhawk Therapeutics raised?
Skyhawk Therapeutics has raised $625M in total disclosed funding across the rounds on record.
Who has invested in Skyhawk Therapeutics?
Fidelity are named among the investors backing Skyhawk Therapeutics.
What was the latest Skyhawk Therapeutics funding round?
No round stage has been disclosed for Skyhawk Therapeutics.
Where is Skyhawk Therapeutics based?
Skyhawk Therapeutics is based in Waltham, Massachusetts.
When did Skyhawk Therapeutics last raise?
The last disclosed Skyhawk Therapeutics round closed in January 2021.
We update the Skyhawk Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Waltham and their backers are listed below.
